ABT vs VCTR · P/E 25, rev $44.33B vs P/E 14, rev $893.5M
Abbott Laboratories (ABT) versus Victory Capital Holdings Inc (VCTR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Not investment advice. Open the ABT and VCTR stock pages for the full models.
Not investment advice.